Jie Yu

Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial

E. Mascha, P. J. Devereaux, Yuguang Huang, 2022, The Lancet.

Primary breast double-hit lymphoma management and outcomes: a real-world multicentre experience

Jie Yu, Tingting Zhang, Hai-rong Fei, 2021, Cancer Cell International.

Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations

He-long Zhang, N. Yang, Sanyuan Sun, 2022, JTO clinical and research reports.

Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer.

Ying Cheng, Baolan Li, Yunpeng Liu, 2019, Translational lung cancer research.

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

W. Xu, Z. Cai, Jing Liu, 2021, Advances in Therapy.

Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20+ B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study

W. Xu, Z. Cai, Jing Liu, 2020, Scientific Reports.

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study

Yang Zhang, Lihua Sun, Chengliang Yin, 2023, Frontiers in Endocrinology.